Todd Alfred Carter
Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $41K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VYGRVoyager Therapeutics, Inc. | Sell Plan | 4,174145,718 held (−3%) | $3.76 | $16K | -49.5% |
| Feb 20SEC | VYGRVoyager Therapeutics, Inc. | Sell Plan | 3,301149,892 held (−2%) | $3.44 | $11K | -44.8% |
| Feb 11SEC | VYGRVoyager Therapeutics, Inc. | Sell | 3,525153,193 held (−2%) | $3.85 | $14K | -50.6% |
- Sell
Chief Scientific Officer Todd Alfred Carter sold $16K of VYGR at $3.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Todd Alfred Carter sold $11K of VYGR at $3.44 — pre-scheduled 10b5-1 plan sale.